购物车
- 全部删除
- 您的购物车当前为空
Ataquimast 用于治疗晚期受体阳性乳腺癌。
为众多的药物研发团队赋能,
让新药发现更简单!
Ataquimast 用于治疗晚期受体阳性乳腺癌。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 780 | 现货 | |
2 mg | ¥ 1,080 | 现货 | |
5 mg | ¥ 1,750 | 现货 | |
10 mg | ¥ 2,590 | 现货 | |
25 mg | ¥ 4,120 | 现货 | |
50 mg | ¥ 5,590 | 现货 | |
100 mg | ¥ 7,500 | 现货 | |
200 mg | ¥ 9,870 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,470 | 现货 |
产品描述 | Ataquimast is used in curing advanced receptor-positive breast cancer. |
分子量 | 239.7 |
分子式 | C11H14ClN3O |
CAS No. | 182316-31-0 |
Smiles | O=C1N(CC)C2=C(C=CC=C2)N=C1NC.[H]Cl |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 14 mg/mL (58.41 mM), Sonication is recommended. ![]() | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
评论内容